Редактирование: PROP1

Homeobox protein prophet of Pit-1 (PROP-1) (Pituitary-specific homeodomain factor)

==Publications==

{{medline-entry
|title=Aged [[PROP1]] deficient dwarf mice maintain ACTH production.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/22145038
|abstract=Humans with [[PROP1]] mutations have multiple pituitary hormone deficiencies (MPHD) that typically advance from growth insufficiency diagnosed in infancy to include more severe growth hormone (GH) deficiency and progressive reduction in other anterior pituitary hormones, eventually including adrenocorticotropic hormone (ACTH) deficiency and hypocortisolism. Congenital deficiencies of GH, prolactin, and thyroid stimulating hormone have been reported in the Prop1(null) (Prop1(-/-)) and the Ames dwarf (Prop1(df/df)) mouse models, but corticotroph and pituitary adrenal axis function have not been thoroughly investigated. Here we report that the C57BL6 background sensitizes mutants to a wasting phenotype that causes approximately one third to die precipitously between weaning and adulthood, while remaining homozygotes live with no signs of illness. The wasting phenotype is associated with severe hypoglycemia. Circulating ACTH and corticosterone levels are elevated in juvenile and aged Prop1 mutants, indicating activation of the pituitary-adrenal axis. Despite this, young adult Prop1 deficient mice are capable of responding to restraint stress with further elevation of ACTH and corticosterone. Low blood glucose, an expected side effect of GH deficiency, is likely responsible for the elevated corticosterone level. These studies suggest that the mouse model differs from the human patients who display progressive hormone loss and hypocortisolism.
|mesh-terms=* Adrenocorticotropic Hormone
* Aging
* Animals
* Blood Glucose
* Corticosterone
* Dwarfism
* Female
* Growth Hormone
* Homeodomain Proteins
* Homozygote
* Hypopituitarism
* Immunoenzyme Techniques
* Male
* Mice
* Mice, Inbred C57BL
* Mice, Knockout
* Mutation
* Phenotype
* Prolactin
* Radioimmunoassay

|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228747
}}
{{medline-entry
|title=The influence of genes on the aging process of mice: a statistical assessment of the genetics of aging.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/15466429
|abstract=Genetic interventions that accelerate or retard aging in mice are crucial in advancing our knowledge over mammalian aging. Yet determining if a given intervention affects the aging process is not straightforward since, for instance, many disease-causing mutations may decrease life span without affecting aging. In this work, we employed the Gompertz model to determine whether several published interventions previously claimed to affect aging in mice do indeed alter the aging process. First, we constructed age-specific mortality tables for a number of mouse cohorts used in longevity experiments and calculated the rate at which mortality increases with age. Estimates of age-independent mortality were also calculated. We found no statistical evidence that [[GHR]]HR, [[IGF1R]], [[INSR]], [[PROP1]], or TRX delay or that [[ATM]]   TERC, BubR1, klotho, [[LMNA]], [[PRDX1]], p53, [[WRN]]   TERC, or [[TOP3B]] accelerate mouse aging. Often, changes in the expression of these genes affected age-independent mortality and so they may prove useful to other aspects of medicine. We found statistical evidence that C/EBP, [[MSRA]], [[SHC1]], growth hormone, [[GHR]], PIT1, and PolgA may influence aging in mice. These results were interpreted together with age-related physiological and pathological changes and provide novel insights regarding the role of several genes in the mammalian aging process.
|mesh-terms=* Aging
* Animals
* Gene Expression
* Genes
* Mice
* Mice, Mutant Strains
* Models, Animal
* Mortality

|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448866
}}